Literature DB >> 9527785

Mechanism of amphotericin B resistance in Leishmania donovani promastigotes.

N Mbongo1, P M Loiseau, M A Billion, M Robert-Gero.   

Abstract

Amphotericin B (AmB)-resistant Leishmania donovani promastigotes were selected by increasing drug pressure, and their biological features were compared with those of the wild-type parent strain. The 50% inhibitory concentration for resistant cells was 20 times higher than that for the wild-type. Resistance was stable after more than 40 passages in drug-free medium, and resistant promastigotes were infective to macrophages in vitro but lost their virulence in vivo. They had 2.5 times longer generation time, decreased AmB uptake, and increased AmB efflux in comparison to the wild type. Fluorescence measurement with a specific plasma membrane probe, 1-[4-(trimethylammonio)-1,6-diphenylhexa]-1,3,5-triene, showed increased membrane fluidity in drug-resistant promastigotes. Analysis of lipid composition showed that in resistant cells saturated fatty acids were prevalent, with stearic acid as the major fatty acid, and the major sterol was an ergosterol precursor, the cholesta-5, 7, 24-trien-3beta-ol and not ergosterol as in the AmB-sensitive strain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9527785      PMCID: PMC105413          DOI: 10.1128/AAC.42.2.352

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

1.  Biochemical alterations in paromomycin-treated Leishmania donovani promastigotes.

Authors:  M Maarouf; F Lawrence; S Brown; M Robert-Gero
Journal:  Parasitol Res       Date:  1997       Impact factor: 2.289

2.  Fluidity-dependent Mg2(+)-ATPase activity in membranes from Leishmania donovani promastigotes.

Authors:  M Dutta; R Bandyopadhyay; C Ghosh; M K Basu
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

Review 3.  Amphotericin B: new life for an old drug.

Authors:  S Hartsel; J Bolard
Journal:  Trends Pharmacol Sci       Date:  1996-12       Impact factor: 14.819

4.  Polyene antibiotic action on lecithin liposomes: effect of cholesterol and fatty acyl chains.

Authors:  C C HsuChen; D S Feingold
Journal:  Biochem Biophys Res Commun       Date:  1973-04-16       Impact factor: 3.575

Review 5.  Carrier effects on biological activity of amphotericin B.

Authors:  J Brajtburg; J Bolard
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

Review 6.  Molecular mechanisms of drug resistance in fungi.

Authors:  H Vanden Bossche; P Marichal; F C Odds
Journal:  Trends Microbiol       Date:  1994-10       Impact factor: 17.079

7.  Comparison of high-performance liquid chromatography and bioassay of amphotericin B in serum.

Authors:  J W Hülsewede; H Dermoumi
Journal:  Mycoses       Date:  1994 Jan-Feb       Impact factor: 4.377

8.  Visceral leishmaniasis in HIV infected patients: treatment with high dose liposomal amphotericin B (AmBisome).

Authors:  R Russo; L C Nigro; S Minniti; A Montineri; L Gradoni; L Caldeira; R N Davidson
Journal:  J Infect       Date:  1996-03       Impact factor: 6.072

9.  Sterols of Leishmania species. Implications for biosynthesis.

Authors:  L J Goad; G G Holz; D H Beach
Journal:  Mol Biochem Parasitol       Date:  1984-02       Impact factor: 1.759

10.  Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala.

Authors:  T R Navin; B A Arana; F E Arana; J D Berman; J F Chajón
Journal:  J Infect Dis       Date:  1992-03       Impact factor: 5.226

View more
  60 in total

Review 1.  Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance.

Authors:  M A Ghannoum; L B Rice
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

2.  Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani.

Authors:  Bidyut Purkait; Ashish Kumar; Nilay Nandi; Abul Hasan Sardar; Sushmita Das; Sudeep Kumar; Krishna Pandey; Vidyananda Ravidas; Manish Kumar; Tripti De; Dharmendra Singh; Pradeep Das
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

Review 3.  Drug resistance in leishmaniasis.

Authors:  Simon L Croft; Shyam Sundar; Alan H Fairlamb
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

4.  Cos-Seq for high-throughput identification of drug target and resistance mechanisms in the protozoan parasite Leishmania.

Authors:  Élodie Gazanion; Christopher Fernández-Prada; Barbara Papadopoulou; Philippe Leprohon; Marc Ouellette
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-09       Impact factor: 11.205

Review 5.  [Kala azar. Rare import and significant differential diagnosis].

Authors:  H Sudeck
Journal:  Internist (Berl)       Date:  2006-08       Impact factor: 0.743

6.  Experimental evaluation of second-line oral treatments of visceral leishmaniasis caused by Leishmania infantum.

Authors:  J P Gangneux; M Dullin; A Sulahian; Y J Garin; F Derouin
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

7.  Combination therapy with tamoxifen and amphotericin B in experimental cutaneous leishmaniasis.

Authors:  Cristiana T Trinconi; Juliana Q Reimão; Jenicer K U Yokoyama-Yasunaka; Danilo C Miguel; Silvia R B Uliana
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

8.  Fatty acid profiles in Leishmania spp. isolates with natural resistance to nitric oxide and trivalent antimony.

Authors:  Alana Freire de Azevedo; Jorge Luís de Lisboa Dutra; Micheli Luize Barbosa Santos; Darlisson de Alexandria Santos; Péricles Barreto Alves; Tatiana Rodrigues de Moura; Roque Pacheco de Almeida; Marcelo Ferreira Fernandes; Ricardo Scher; Roberta Pereira Miranda Fernandes
Journal:  Parasitol Res       Date:  2013-10-06       Impact factor: 2.289

9.  Amphotericin B-loaded nanoparticles for local treatment of cutaneous leishmaniasis.

Authors:  Aiman Abu Ammar; Abed Nasereddin; Suheir Ereqat; Mary Dan-Goor; Charles L Jaffe; Eyal Zussman; Ziad Abdeen
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

10.  Identification of new leishmanicidal peptide lead structures by automated real-time monitoring of changes in intracellular ATP.

Authors:  J Román Luque-Ortega; José M Saugar; Cristina Chiva; David Andreu; Luis Rivas
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.